Lantheus Medical Imaging Inc, Billerica, Mass, announced that it has entered into a new agreement with FujiFilm RI Pharma Co Ltd to license and distribute Cardiolite, a kit for the preparation of Technetium Tc99m Sestamibi for injection, and Neurolite, a kit for the preparation of Technetium Tc99m Bicisate for injection, in Japan. Under the terms of the 10-year agreement effective January 1, 2013, which immediately follows an earlier 10-year agreement with FRI, Lantheus will continue to supply FRI with Cardiolite and Neurolite in finished form as well as provide the raw materials to manufacture and sell the products in unit dose form. Cardiolite and Neurolite are technetium-based radiopharmaceutical imaging agents used in single-photon emission computed tomography (SPECT).